Quentin M. Anstee  
Associate Editor
Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, UK

Prof Quentin M. Anstee is Professor of Experimental Hepatology and Deputy-Director of the Institute of Cellular Medicine, Newcastle University, UK. A practicing clinician, he is also an Honorary Consultant Hepatologist in the Liver Unit at the Freeman Hospital, where he leads one of the largest NAFLD clinical services in the U.K. His translational research has extended from the bench to the bedside with particular focus on Non-Alcoholic Fatty Liver Disease. He trained in medicine at University College London where he was awarded a First Class Honours degree and won First Prize in Medicine in the final MB BS examination. He coordinates two major EU funded international research consortia that are studying NAFLD pathogenesis and developing/validating biomarkers to assist the diagnosis, risk-stratification and monitoring of patients with NAFLD: ‘LITMUS’ Liver Investigation: Testing Marker Utility in Steatohepatitis (EU IMI2 funded) and ‘EPoS’ Elucidating Pathways of Steatohepatitis (EU H2020 funded).